Basic Information
Mannin Research is a biotechnology company developing a unique set of molecules to treat vascular-related diseases, such as primary open-angle glaucoma, pediatric glaucoma, cystic kidney disease, and inflammation. Their lead indication, MAN-01, targets the treatment of primary open-angle glaucoma. The company is also developing a small molecule drug that is easy to administer in the form of eye drops to reduce intraocular pressure (IOP) in glaucoma progression.